Cargando…

Temozolomide-Induced Changes in Gut Microbial Composition in a Mouse Model of Brain Glioma

BACKGROUND: Gut microbiota is associated with the progression of brain tumors. However, the alterations in gut microbiota observed during glioma growth and temozolomide (TMZ) therapy remain poorly understood. METHODS: C57BL/6 male mice were implanted with GL261 glioma cells. TMZ/sodium carboxymethyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xiao-Chong, Wu, Bang-Sheng, Jiang, Yi, Li, Jie, Wang, Ze-Fen, Ma, Chao, Li, Yi-Rong, Yao, Jie, Jin, Xiao-Qing, Li, Zhi-Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071088/ https://www.ncbi.nlm.nih.gov/pubmed/33907383 http://dx.doi.org/10.2147/DDDT.S298261

Ejemplares similares

Glioma and temozolomide induced alterations in gut microbiome
por: Patrizz, Anthony, et al.
Publicado: (2020)

Heparanase confers temozolomide resistance by regulation of exosome secretion and circular RNA composition in glioma
por: Si, Jinchao, et al.
Publicado: (2021)

Exosomal connexin 43 regulates the resistance of glioma cells to temozolomide
por: Yang, Zhang-Jian, et al.
Publicado: (2021)

Inhibition of Elongation Factor-2 Kinase Augments the Antitumor Activity of Temozolomide against Glioma
por: Liu, Xiao-yuan, et al.
Publicado: (2013)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux
por: Wen, Zhi-peng, et al.
Publicado: (2019)

Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
por: Lv, Qiao-Li, et al.
Publicado: (2020)

Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma
por: Shao, Naiyuan, et al.
Publicado: (2018)

Pyrrolidine dithiocarbamate sensitizes U251 brain glioma cells to temozolomide via downregulation of MGMT and BCL-XL
por: Tang, Jun-Hai, et al.
Publicado: (2017)

Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
por: Hou, Xiaoying, et al.
Publicado: (2023)

Composition and immuno-stimulatory properties of extracellular DNA from mouse gut flora
por: Qi, Ce, et al.
Publicado: (2017)

Correction to: Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma
por: Shao, Naiyuan, et al.
Publicado: (2022)

Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells
por: Jin, Feng, et al.
Publicado: (2017)

Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2
por: Zhang, Xin, et al.
Publicado: (2018)

Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells
por: Ma, Jian, et al.
Publicado: (2016)

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis
por: Tang, Jun-Hai, et al.
Publicado: (2019)

Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas
por: Li, Ming-Yang, et al.
Publicado: (2016)

MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7
por: Liu, Zhi-Qin, et al.
Publicado: (2020)

Effects of Spermidine on Mouse Gut Morphology, Metabolites, and Microbial Diversity
por: Jiang, Dong-Mei, et al.
Publicado: (2023)

Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
por: Gu, Qiang, et al.
Publicado: (2023)

Effect of temozolomide on livin and caspase-3 in U251 glioma stem cells
por: LI, GENHUA, et al.
Publicado: (2015)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma
por: Wei, Shoufeng, et al.
Publicado: (2022)

Could upfront temozolomide chemotherapy postpone the need for radiotherapy in young patients with high-risk low-grade gliomas?
por: Li, Ze-Yang, et al.
Publicado: (2021)

Catabolism of Dictyophora indusiata Polysaccharide and Its Impacts on Gut Microbial Composition during In Vitro Digestion and Microbial Fermentation
por: Zhao, Yun-Xuan, et al.
Publicado: (2023)

Impact of beta‐2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment
por: Tang, Feng, et al.
Publicado: (2021)

Differential Characterization of Temozolomide-Resistant Human Glioma Cells
por: Lai, Sheng-Wei, et al.
Publicado: (2018)

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma
por: Liu, Zhen-Yuan, et al.
Publicado: (2023)

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng, Yuan, et al.
Publicado: (2018)

CD90(low) glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
por: Xue, Bing-zhou, et al.
Publicado: (2021)

Identifying Predictive Gene Expression and Signature Related to Temozolomide Sensitivity of Glioblastomas
por: Cai, Hong-Qing, et al.
Publicado: (2020)

Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
por: Yu, Zhiyun, et al.
Publicado: (2015)

Acquired temozolomide resistance in MGMT(low) gliomas is associated with regulation of homologous recombination repair by ROCK2
por: Zhang, Xin, et al.
Publicado: (2022)

Mechanism of NURP1 in temozolomide resistance in hypoxia-treated glioma cells via the KDM3A/TFEB axis
por: LI, TAO, et al.
Publicado: (2023)

Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
por: Qiu, Zhi-Kun, et al.
Publicado: (2014)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

Microbial composition in different gut locations of weaning piglets receiving antibiotics
por: Li, Kaifeng, et al.
Publicado: (2017)

Correction to: CD90(low) glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
por: Xue, Bing-zhou, et al.
Publicado: (2021)

Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma
por: Yang, Pei, et al.
Publicado: (2016)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_54310asnjf86vbu9ceht3ns0i2